We develop next-generation retinal imaging technology combining adaptive optics (AO), originally used in astronomy, with optical coherence tomography (OCT). Our platform enables three-dimensional visualization of retinal microstructures and cells, supported by AI-driven analysis.
Fast Imaging
Retinal scans in just 2 seconds
Non-Invasive
Safe, contact-free, in vivo imaging
High Resolution
Visualization of cells and microstructures
Novel Contrast
Revealing previously invisible structures
AI-Based Analysis
Automated evaluation of imaging data
Repeatable Measurements
Enabling longitudinal studies and monitoring
Thyra Imaging is a MedTech spin-off from the Medical University of Vienna, founded in 2026 with the goal of translating advanced imaging technology into real-world applications. Originally developed for astronomical telescopes, AO has been advanced towards clinical maturity at the Medical University of Vienna and is used in combination with OCT to enable a new level of resolution in retinal imaging. By integrating this technology with AI-driven analysis, Thyra Imaging enables new biomarkers and applications in research, drug development, and clinical practice.
Proposal
We develop an integrated platform combining advanced retinal imaging hardware with AI-driven software for scalable data acquisition and analysis.
Value
Our technology enables reliable access to cellular-level retinal information, supporting more precise disease characterization and longitudinal monitoring.
Applications
The retina provides a unique window into the brain. Our platform enables applications beyond ophthalmology, including insights into neurological diseases.
Supported by:
